General Information of the m6A Target Gene (ID: M6ATAR00848)
Target Name AC026356.1
Gene Name AC026356.1
Full List of Crosstalk(s) between m6A Modification and Epigenetic Regulation Related to This Regulator
Histone modification
m6A Regulator: Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2)
In total 1 item(s) under this m6A regulator
Crosstalk ID: M6ACROT03468
Epigenetic Regulator Histone-lysine N-methyltransferase SETD1A (SETD1A)
Regulated Target Histone H3 lysine 4 trimethylation (H3K4me3)
Crosstalk relationship Histone modification → m6A
Disease Lung cancer
Non-coding RNA
m6A Regulator: Wilms tumor 1-associating protein (WTAP)
In total 1 item(s) under this m6A regulator
Crosstalk ID: M6ACROT05655
Epigenetic Regulator AC026356.1
Regulated Target Interleukin-11 (IL11)
Crosstalk relationship m6A → ncRNA
Disease Liver cancer
m6A Regulator: Methyltransferase-like 3 (METTL3)
In total 1 item(s) under this m6A regulator
Crosstalk ID: M6ACROT05656
Epigenetic Regulator AC026356.1
Regulated Target Interleukin-11 (IL11)
Crosstalk relationship m6A → ncRNA
Disease Liver cancer
m6A Regulator: Methyltransferase-like 14 (METTL14)
In total 1 item(s) under this m6A regulator
Crosstalk ID: M6ACROT05773
Epigenetic Regulator AC026356.1
Crosstalk relationship m6A → ncRNA
Disease Lung cancer
m6A Regulator: Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2)
In total 1 item(s) under this m6A regulator
Crosstalk ID: M6ACROT05774
Epigenetic Regulator AC026356.1
Crosstalk relationship m6A → ncRNA
Disease Lung cancer
References
Ref 1 BiPar Sciences Co-founder Reunites Management Team At TriAct Therapeutics to Advance Clinical Stage Cancer Programs. TriAct Therapeutics. Sept. 10, 2009.
Ref 2 Clinical pipeline report, company report or official report of Gan & Lee Pharmaceuticals.